Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liffert Vogt

Showing results (21-30 of 191) with videos related to

Pageof 20
Sort By:
JAMA Internal Medicine|October 5, 2018
Hydrochlorothiazide and the Risk of Malignant MelanomaBert-Jan H van den Born, Rik Olde-Engberink, Liffert Vogt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 13, 2003
Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reductionLiffert Vogt, Gozewijn D Laverman, Robin P F Dullaart, et al.
Hypertension (Dallas, Tex. : 1979)|April 18, 2018
Sodium Handling by the Blood Vessel Wall: Critical for Hypertension DevelopmentEliane F E Wenstedt, Rik H G Olde Engberink, Liffert Vogt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2008
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patientsLiffert Vogt, Dick de Zeeuw, Arend Jan J Woittiez, et al.
Journal of the American Society of Nephrology : JASN|February 15, 2008
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartanLiffert Vogt, Femke Waanders, Frans Boomsma, et al.
Nature Reviews. Nephrology|May 6, 2026
Author Correction: Salt and chronic kidney diseaseJacob Murray, Roos F Marsman, Rik H Olde Engberink, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2025
Stratified medicine for blood pressure targets in type 2 diabetes mellitusBeatriz Fernandez-Fernandez, Jose M Valdivielso, Liffert Vogt, et al.
Clinical Kidney Journal|October 4, 2021
Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKDRosa D Wouda, Femke Waanders, Dick de Zeeuw, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2025
Purinoreceptor P2X7 in Extracellular ATP-Mediated Inflammation through the Spectrum of Kidney Diseases and Kidney TransplantationJuan Miguel Téllez Garcia, Thei Steenvoorden, Frederike Bemelman, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2020
Authors' ReplyDidier Collard, Lennart van de Velde, Liffert Vogt, et al.
Pageof 20

Showing results (21-30 of 191) with videos related to

Sort By:
Pageof 20
JAMA Internal Medicine|October 5, 2018
Hydrochlorothiazide and the Risk of Malignant MelanomaBert-Jan H van den Born, Rik Olde-Engberink, Liffert Vogt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 13, 2003
Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reductionLiffert Vogt, Gozewijn D Laverman, Robin P F Dullaart, et al.
Hypertension (Dallas, Tex. : 1979)|April 18, 2018
Sodium Handling by the Blood Vessel Wall: Critical for Hypertension DevelopmentEliane F E Wenstedt, Rik H G Olde Engberink, Liffert Vogt
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2008
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patientsLiffert Vogt, Dick de Zeeuw, Arend Jan J Woittiez, et al.
Journal of the American Society of Nephrology : JASN|February 15, 2008
Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartanLiffert Vogt, Femke Waanders, Frans Boomsma, et al.
Nature Reviews. Nephrology|May 6, 2026
Author Correction: Salt and chronic kidney diseaseJacob Murray, Roos F Marsman, Rik H Olde Engberink, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 13, 2025
Stratified medicine for blood pressure targets in type 2 diabetes mellitusBeatriz Fernandez-Fernandez, Jose M Valdivielso, Liffert Vogt, et al.
Clinical Kidney Journal|October 4, 2021
Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKDRosa D Wouda, Femke Waanders, Dick de Zeeuw, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2025
Purinoreceptor P2X7 in Extracellular ATP-Mediated Inflammation through the Spectrum of Kidney Diseases and Kidney TransplantationJuan Miguel Téllez Garcia, Thei Steenvoorden, Frederike Bemelman, et al.
Journal of the American Society of Nephrology : JASN|November 10, 2020
Authors' ReplyDidier Collard, Lennart van de Velde, Liffert Vogt, et al.
Pageof 20